Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

The Foundation in Evidence of Medical and Dental Telephone Consultations.

Albrecht M, Isenbeck F, Kasper J, Mühlhauser I, Steckelberg A.

Dtsch Arztebl Int. 2016 Jun 6;113(22-23):389-95. doi: 10.3238/arztebl.2016.0389.

2.

Cell free fetal DNA testing in maternal blood of Romanian pregnant women.

Radoi VE, Bohiltea CL, Bohiltea RE, Albu DN.

Iran J Reprod Med. 2015 Oct;13(10):623-6.

3.

Impact of Cell-Free Fetal DNA Screening on Patients' Choice of Invasive Procedures after a Positive California Prenatal Screen Result.

Shah FT, French KS, Osann KE, Bocian M, Jones MC, Korty L.

J Clin Med. 2014 Jul 24;3(3):849-64. doi: 10.3390/jcm3030849.

4.

Explore the dynamic alternation of gene PLAC4 mRNA expression levels in maternal plasma in second trimester for nonivasive detection of trisomy 21.

Yang L, Sun HY, Chen DZ, Lu MD, Tang Y, Xiao JP.

Obstet Gynecol Sci. 2015 Jul;58(4):261-7. doi: 10.5468/ogs.2015.58.4.261. Epub 2015 Jul 16.

5.

Developmental stage determines efficiency of gene transfer to muscle satellite cells by in utero delivery of adeno-associated virus vector serotype 2/9.

Stitelman DH, Brazelton T, Bora A, Traas J, Merianos D, Limberis M, Davey M, Flake AW.

Mol Ther Methods Clin Dev. 2014 Sep 10;1:14040. doi: 10.1038/mtm.2014.40. eCollection 2014.

6.

Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele.

Wang A, Brown EG, Lankford L, Keller BA, Pivetti CD, Sitkin NA, Beattie MS, Bresnahan JC, Farmer DL.

Stem Cells Transl Med. 2015 Jun;4(6):659-69. doi: 10.5966/sctm.2014-0296. Epub 2015 Apr 24.

7.

Prenatal screening of cytogenetic anomalies - a Western Indian experience.

Sheth F, Rahman M, Liehr T, Desai M, Patel B, Modi C, Trivedi S, Sheth J.

BMC Pregnancy Childbirth. 2015 Apr 12;15:90. doi: 10.1186/s12884-015-0519-y.

8.

Biology of infantile hemangioma.

Itinteang T, Withers AH, Davis PF, Tan ST.

Front Surg. 2014 Sep 25;1:38. doi: 10.3389/fsurg.2014.00038. eCollection 2014. Review.

9.

The Maternal Serological Response to Intrauterine Ureaplasma sp. Infection and Prediction of Risk of Pre-Term Birth.

Ireland DJ, Keelan JA.

Front Immunol. 2014 Dec 9;5:624. doi: 10.3389/fimmu.2014.00624. eCollection 2014. Review.

10.

Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis.

Neyt M, Hulstaert F, Gyselaers W.

BMJ Open. 2014 Nov 7;4(11):e005922. doi: 10.1136/bmjopen-2014-005922.

11.

A framework for analyzing sex-selective abortion: the example of changing sex ratios in Southern Caucasus.

Hohmann SA, Lefèvre CA, Garenne ML.

Int J Womens Health. 2014 Oct 20;6:889-97. doi: 10.2147/IJWH.S66333. eCollection 2014.

12.

Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples.

McCullough RM, Almasri EA, Guan X, Geis JA, Hicks SC, Mazloom AR, Deciu C, Oeth P, Bombard AT, Paxton B, Dharajiya N, Saldivar JS.

PLoS One. 2014 Oct 7;9(10):e109173. doi: 10.1371/journal.pone.0109173. eCollection 2014.

13.

Comparison of complications of chorionic villus sampling and amniocentesis.

Shahbazian N, Barati M, Arian P, Saadati N.

Int J Fertil Steril. 2012 Jan;5(4):241-4. Epub 2012 Mar 20.

14.

The first 3,000 Non-Invasive Prenatal Tests (NIPT) with the Harmony test in Belgium and the Netherlands.

Willems PJ, Dierickx H, Vandenakker E, Bekedam D, Segers N, Deboulle K, Vereecken A.

Facts Views Vis Obgyn. 2014;6(1):7-12.

15.

Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification.

Devonshire AS, Whale AS, Gutteridge A, Jones G, Cowen S, Foy CA, Huggett JF.

Anal Bioanal Chem. 2014 Oct;406(26):6499-512. doi: 10.1007/s00216-014-7835-3. Epub 2014 May 24.

16.

Percutaneous in utero thoracoamniotic shunt creation for fetal thoracic abnormalities leading to nonimmune hydrops.

White SB, Tutton SM, Rilling WS, Kuhlmann RS, Peterson EL, Wigton TR, Ames MB.

J Vasc Interv Radiol. 2014 Jun;25(6):889-94. doi: 10.1016/j.jvir.2014.02.009. Epub 2014 Apr 1.

17.

Noninvasive prenatal testing: the future is now.

Norwitz ER, Levy B.

Rev Obstet Gynecol. 2013;6(2):48-62. Review.

18.

Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21.

Lim JH, Lee da E, Park SY, Kim do J, Ahn HK, Han YJ, Kim MY, Ryu HM.

BMC Med Genomics. 2014 Jan 8;7:1. doi: 10.1186/1755-8794-7-1.

19.

Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood.

Lim JH, Park SY, Ryu HM.

Obstet Gynecol Sci. 2013 Mar;56(2):58-66. doi: 10.5468/OGS.2013.56.2.58. Epub 2013 Mar 12. Review.

20.

Mosaic pregnancy after transfer of a "euploid" blastocyst screened by DNA microarray.

Haddad G, He W, Gill J, Witz C, Wang C, Kaskar K, Wang W.

J Ovarian Res. 2013 Oct 8;6(1):70. doi: 10.1186/1757-2215-6-70.

Items per page

Supplemental Content

Write to the Help Desk